Indication
Factor VII Deficiency
1 clinical trial
1 product
Clinical trial
To Evaluate the Safety, PK/PD and Immunogenicity of SS109 in Hemophilia Patients With Blood Coagulation Factor Ⅷ or Ⅸ Inhibitors After Single Administration, Open Label, Dose Escalation, and Multicenter Phase I Clinical TrialStatus: Completed, Estimated PCD: 2023-03-31
Product
SS109